Introduction There is no national standard treatment for patients with breast lobular
carcinoma in situ (LCIS). Association of Breast Surgery guidelines for the management of …

Lobular carcinoma in situ (LCIS) exists as two main subtypes, classic and pleomorphic.
While it may sometimes be an invasive cancer precursor, LCIS can be treated as a risk …

Purpose of investigation: to show management of patients with breast lobular carcinoma in
situ (LCIS). Materials and Methods: This study is the retrospective review of 65 patients …

Lobular carcinoma in situ (LCIS) has gone from a rare form of mammary cancer to a marker
of increased risk. Treatment options have undergone a corresponding change from …

Background Studies report low upgrade rates following excision for classic-type lobular
carcinoma in situ (LCIS) with radiologic-pathologic concordance. Thus, in the absence of …

Background: The finding of lobular carcinoma in situ (LCIS) in the breast has generally
prompted treatment with unilateral or bilateral mastectomy. Most experts now feel that LCIS …

Objective To determine the risk of breast cancer due to lobular carcinoma in situ (LCIS).
Methods This retrospective IRB-approved study identified cases of LCIS after percutaneous …

The article discusses a survey of self-reported breast surgeons which revealed that there
was no consensus for surgical treatment of Pleomorphic Lobular Carcinoma in Situ (PLCIS) …

Results: Median age of patients (mean±SD, range) was 56 years (56.6±9.7, 36–74), while
median size of LCIS was 15 mm (15.3±5.9, 6–28). Final examination demonstrated IBC foci …

BACKGROUND: The understanding of lobular carcinoma in situ (LCIS) has evolved since it
was first described. LCIS once was thought to be a premalignant condition, but now it is …